About
Ingemar Ernberg is a Senior Professor at Karolinska Institutet, affiliated with the Department of Microbiology, Tumor and Cell Biology. He is part of the Development of small molecules restoring the tumor suppression functions of p53 – Galina Selivanova Group and the Division of Tumor Biology. His research focuses on viral oncogenesis, particularly the role of Epstein-Barr virus (EBV) in cancers like nasopharyngeal carcinoma (NPC), and integrates molecular biology, genomics, and clinical oncology to advance precision medicine and understand cancer mechanisms.
Educations: Docent (Associate Professor) at Karolinska Institutet since 1981. No explicit doctoral degree details are provided in the text.
Research interests include Cancer and Oncology, Cell and Molecular Biology, Medical Microbiology, Virology, and Genetic Epidemiology. He explores how EBV interacts with host genetics and environmental factors to influence cancer development, with a focus on tumor suppression pathways and molecular tumor board systems for clinical decision support.
Recent publications highlight work on personalized cancer medicine implementation, NPC causal models, and the role of MTSS1 in tumor biology. He collaborates extensively in international initiatives to address global health disparities in cancer care and prevention.
No scientific awards are explicitly mentioned. Ingemar has advised no formally listed students, though he contributes to collaborative research teams. His involvement in infrastructure projects like the Molecular Tumor Board Portal demonstrates commitment to advancing clinical oncology through technology and interdisciplinary approaches.
He is associated with the Single Cell Atlas initiative and the Cancer Core Europe network, contributing to cutting-edge research in tumor biology and precision medicine systems.
